Artilysin® - Overview
Since the rise in multi-drug resistant infections seems unstoppable, alternative strategies to combat these pathogens are urgently needed.
Artilysin® is a new antimicrobial platform technology to combat bacterial pathogens in a wide range of applications. Due to the innovative platform character, it is possible to design specific Artilysin®s to target nearly every bacterial species. Even multi-drug resistant or persistent cells can be addressed by the unique mode of action.